Researcher Shirai from DMPK BU to Deliver an Oral Presentation at the 16th Annual Conference on Biomolecular Screenology

2025.11.18

Researcher Shirai from the DMPK Business Unit, will deliver a oral presentation at the 16th Annual Conference of Conference on Biomolecular Screenology, to be held in Funabori, Tokyo in Japan.
If you plan to attend the conference, we encourage you to join the session and hear the presentation.

Conference Name: The 16th Annual Conference of Conference on Biomolecular Screenology

Date & Time: November 27, 10:30~15:00 (JST)

Location: Tower Hall Funabori, Tokyo Edogawa, Japan

Title: Streamlining HT-ADME Screening Workflow
SIG.1 HT-ADMET

Presentation Summary
Our HT-ADME platform offers a wide variety of high-capacity assays with short turnaround times and low costs. These features enable rapid compound optimization during the drug discovery stage. This presentation introduces our initiatives including of creation and use of original tools, utilization of Excel macros and functions, assay automation, utilization of RPA, etc., to improve the efficiency of the HT-ADME screening workflow. Our initiatives cover everything from request acceptance, compound supply, assay execution, measurement, data analysis, and report preparation.

Axcelead DDP’s Soulution
Axcelead offers a wide variety of HT-ADME screening services for compound optimization. Our HT-ADME platform can deliver the assay results within one week. Our proprietary platform is scalable and cost-effective, even for a single compound. In addition, we can quickly establish a new assay system appropriate for your modalities. Please contact us to learn more about our HT-ADME screening services.